Rheumatology

In this interview, Ying-Ying Leung, MB, ChB, MD, answers questions about her team’s recently published article titled “Expert Perspective: Management of the Psoriatic Arthritis Patient After Failure of One...

In this expert Q&A, Cécile Philippoteaux, MD, MSc, PharmD, discusses the results of her team’s recent review, including the prevalence, characteristics, definition, and the next steps for research in...

Gulsen Ozen, MD, answers questions about her team’s research in the use of statins to help reduce the risk of cardiovascular disease and type 2 diabetes in individuals with rheumatoid arthritis.

Elizabeth Volkmann, MD, associate professor at UCLA, Director of the Scleroderma Program, and the codirector of UCLA's Connective Tissue Disease-Related Interstitial Lung Disease program, discusses treating...

Kevin Hackshaw, MD, answers our questions about his study that identified a blood test as a potential biomarker for the diagnosis of fibromyalgia and other rheumatic disorders.

Mohit Bhandari, MD, answers our questions about the HEALTH trial, which investigated the effect of a total hip arthroplasty compared with hemiarthroplasty among patients with femoral neck fracture.

Lead author Lihi Eder, MD, PhD, answers our questions about her study that evaluated musculoskeletal issues preceding patients’ diagnosis of psoriatic arthritis. This period may represent a window for...

Peter Mandl, MD, PhD, answers our questions about his research that shed light on the advantages and disadvantages of implementing imaging techniques into a treat-to-target approach in psoriatic arthritis...

Marita Cross, PhD, from the Institute of Bone and Joint Research at the University of Sydney, answers our questions about her research on the global burden of rheumatoid arthritis.

In this Q&A, Dr Machado answers our questions about the impact that biologic disease-modifying antirheumatic drugs have in axial spondyloarthritis remission.